EUVIMEDEUVIMED entdecken
Open Access

Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity

Helin Tercan iD, Benjamin C Cossins, Rosanne C van Deuren iD, Joost H W Rutten iD, Leo A B Joosten iD, Mihai G Netea, Alexander Hoischen iD, Siroon Bekkering iD, Niels P Riksen iD

Journal of the American Heart Association · 16.01.2024 · 13 (2)

DOI: 10.1161/jaha.123.031665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 16.01.2024. Verfasst von Helin Tercan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radboud University Medical Center Department of Internal Medicine Nijmegen the Netherlands. Hauptthemen laut MEDLINE: Metabolic Syndrome, Atherosclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is accompanied by dysregulated inflammation, which can contribute to vasculometabolic complications including metabolic syndrome and atherosclerosis. Recently, clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a risk factor for cardiovascular diseases. We aimed to determine how CHIP is related to immune cell function, systemic inflammation, and vasculometabolic complications in obese individuals. Methods and Results Two hundred ninety‐seven individuals with overweight and obesity, between the ages of 54 and 81 years, were recruited in a cross‐sectional study. Clonal hematopoiesis driver mutations (CHDMs) were identified with an ultrasensitive targeted assay. Assessment of carotid artery atherosclerosis was performed with ultrasound. Detailed immunological parameters, including cytokine production capacity of peripheral blood mononuclear cells, and targeted plasma proteomics analysis, were studied. Adipose tissue inflammation was determined in subcutaneous fat biopsies. Individuals with CHIP had higher concentrations of circulating IL (interleukin)‐6. Total number of leukocytes and neutrophils were higher in individuals with CHIP. In contrast, ex vivo cytokine production capacity of peripheral blood mononuclear cells was significantly lower in individuals with CHIP. Sex‐stratified analysis showed that men with CHDMs had significantly higher leukocyte and neutrophil counts, and ex vivo cytokine production capacity was lower in women with CHDMs. Surprisingly, the presence of atherosclerotic plaques was significantly lower in individuals with CHDMs. There was no relation between CHIP and metabolic syndrome.

Conclusions

In individuals with overweight or obesity, CHDMs are not associated with vasculometabolic complications, but rather with a lower presence of carotid plaques. CHDMs associate with increased circulating inflammatory markers and leukocyte numbers, but a lower peripheral blood mononuclear cell cytokine production capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeAtherosclerosisMaleHumansFemaleMiddle AgedAgedAged, 80 and overClonal HematopoiesisLeukocytes, MononuclearCross-Sectional StudiesOverweightHematopoiesisObesityInflammationInterleukin-6Mutation

Stichwörter der Autor:innen

atherosclerosisclonal hematopoiesisimmunological parametersobesity

Substanzen

Interleukin-6

Autor:innen und Institutionen

  • Radboud University Medical Center Department of Internal Medicine Nijmegen the Netherlands.
  • Radboud University Medical Center Department of Human Genetics Nijmegen the Netherlands.
  • Department of Medical Genetics Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca Romania.
  • Department for Immunology and Metabolism, Life and Medical Sciences Institute (LIMES) University of Bonn Germany.

ORCID-Profile: Helin Tercan, Rosanne C van Deuren, Joost H W Rutten, Leo A B Joosten, Alexander Hoischen, Siroon Bekkering, Niels P Riksen

Zitieren

APA

Tercan, H., Cossins, B. C., van Deuren, R. C., Rutten, J. H. W., Joosten, L. A. B., Netea, M. G., Hoischen, A., Bekkering, S., & Riksen, N. P. (2024). Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity. Journal of the American Heart Association, 13(2). https://doi.org/10.1161/jaha.123.031665

Vancouver

Tercan H, Cossins BC, van Deuren RC, Rutten JHW, Joosten LAB, Netea MG, et al. Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity. Journal of the American Heart Association. 2024;13(2). doi:10.1161/jaha.123.031665

BibTeX
@article{Tercan2024,
  author = {Tercan, Helin and Cossins, Benjamin C and van Deuren, Rosanne C and Rutten, Joost H W and Joosten, Leo A B and Netea, Mihai G and Hoischen, Alexander and Bekkering, Siroon and Riksen, Niels P},
  title = {Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {2},
  doi = {10.1161/jaha.123.031665}
}
Kostenlos starten →